Masahiro Takeyama

22PUBLICATIONS
33CO-AUTHORS
HaematologyNanotoxicology, health and safetyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Respiratory diseasesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Aug 14, 2026
Current State of Moderate Congenital Haemophilia A and the Need for Preventive Treatment.

|Feb 05, 2026
NXTAGE: a phase 1/2 study of NXT007 to assess safety, pharmacokinetics, and efficacy in hemophilia A without inhibitors.

Keiji Nogami, Chur-Woo You, Young-Shil Park

|Nov 26, 2025
Comprehensive anticoagulant effect of heparinoid in blood samples from patients with hemophilia.

Tomoya Miyatake, Masahiro Takeyama, Kaoru Horiuchi

|Nov 11, 2025
Emicizumab enhances the ex vivo coagulant potential in plasma samples from patients with von Willebrand disease.

Mutsumi Yabe, Shoko Furukawa, Masahiro Takeyama

|Mar 16, 2025
Therapeutic switch from plasma to recombinant ADAMTS13 for patients with congenital TTP from Japanese real-world data.

Kazuya Sakai, Atsushi Hamamura, Yoshiko Yoshimura

|Jan 21, 2025
Structural Conformation and the Binding of Factor VIII R2159C (FVIII-Ise) Mutated in the C1 Domain to Phospholipid.

Kuniyoshi Mizumachi, Masahiro Takeyama, Kaoru Horiuchi

Pageof 4

Frequent Collaborators

6 joint publications

Keiji Nogami

6 joint publications

Naruto Shimonishi

5 joint publications

Shoko Furukawa

5 joint publications

Yuto Nakajima